A Clinical Trial of YH23537 in Patients With Knee Osteoarthritis

• Status: Completed
• Trial end date: 2017-09-26
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate efficacy and safety of YH23537 versus celebrex in patients with knee osteoarthritis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Yuhan Corporation
• Treatments: Celecoxib

Criteria

Inclusion Criteria:

• Signed Informed Consent

• Men and women ≥ 40 years of age

• Patients with knee osteoarthritis at one or both knee by ACR

Exclusion Criteria:

• Patients with known or suspected secondary knee osteoarthritis

• Other exclusions applied